孵卵器 发表于 2025-3-26 22:46:21

Marjoke Bakker,Marja van den Heuvel-Panhuizen,Sylvia van Borkulo,Alexander RobitzschIndia since August 2006, and is a potential anti-leishmanial drug that is being used in combination therapy. Amphotericin B, or its liposomal compound (AmBisome), remains the most potent drug with a cure rate of 98–100 % in all resistant cases of VL. Since 2015, single dose AmBisome (10 MKD) is bein

纤细 发表于 2025-3-27 01:15:26

Charles-Frederik Hollemeersch,Bart Pieters,Peter Lambert,Rik Van de WalleIndia since August 2006, and is a potential anti-leishmanial drug that is being used in combination therapy. Amphotericin B, or its liposomal compound (AmBisome), remains the most potent drug with a cure rate of 98–100 % in all resistant cases of VL. Since 2015, single dose AmBisome (10 MKD) is bein

Pamphlet 发表于 2025-3-27 05:34:34

Sylvia van Borkulo,Marja van den Heuvel-Panhuizen,Marjoke Bakker,Hanneke Loomansshown excellent performance on the Indian subcontinent, but the latter is preferred, as it is simpler to use. The proper implementation of these diagnostic strategies within the VL elimination program involves not only the procurement, training, and supervision of staff, but also quality control bot

oncologist 发表于 2025-3-27 12:20:55

http://reply.papertrans.cn/87/8655/865474/865474_34.png

解脱 发表于 2025-3-27 14:54:13

Pau Yanez,Xavier Maseffects and can cure more than 95% of VL patients with a single infusion, but it is very expensive. Hence, the Drugs for Neglected Diseases initiative (Geneva, Switzerland) in collaboration with the Indian Medical Research Council (Rajendra Memorial Research Institute, Patna, India) and the Kala-Aza

Host142 发表于 2025-3-27 19:16:22

Jan-Henk Annema,Yorick Poels,Bieke Zaman,Frederik Cornillieeffects and can cure more than 95% of VL patients with a single infusion, but it is very expensive. Hence, the Drugs for Neglected Diseases initiative (Geneva, Switzerland) in collaboration with the Indian Medical Research Council (Rajendra Memorial Research Institute, Patna, India) and the Kala-Aza

Toxoid-Vaccines 发表于 2025-3-28 01:36:43

http://reply.papertrans.cn/87/8655/865474/865474_37.png

Amorous 发表于 2025-3-28 05:49:17

http://reply.papertrans.cn/87/8655/865474/865474_38.png

Itinerant 发表于 2025-3-28 06:52:38

http://reply.papertrans.cn/87/8655/865474/865474_39.png

nocturia 发表于 2025-3-28 13:06:46

http://reply.papertrans.cn/87/8655/865474/865474_40.png
页: 1 2 3 [4] 5 6
查看完整版本: Titlebook: Serious Games: The Challenge; ITEC/CIP/T 2011: Joi Stefan Wannemacker,Sylke Vandercruysse,Geraldine C Conference proceedings 2012 Springer-